Abstract:Superoxide dismutases (SODs) are a group of metalloenzymes that catalyze the dismutation of superoxide radicals (O2˙-) into hydrogen peroxide (H2O2) and oxygen (O2). As the first line of defense against reactive oxygen species (ROS)-mediated damage, SODs are expected to play an important role in the treatment of oxidative stress-related diseases. However, the clinical applications of SODs have been severely limited by their structural instability and high cost. Compared with natural enzymes, nanozymes, nanomaterials with enzyme-like activity, are more stable, and economical, can be easily modified and their activities can be adjusted. Due to their excellent characteristics, nanozymes have attracted widespread attention in recent years and are expected to become effective substitutes for natural enzymes in many application fields. Importantly, some nanozymes with SOD-like activity have been developed and proved to have a mitigating effect on diseases caused by oxidative stress. These studies on SOD-like nanozymes provide a feasible strategy for breaking through the dilemma of SOD clinical applications. However, at present, the specific catalytic mechanism of SOD-like nanozymes is still unclear, and many important issues need to be resolved. Although there are many comprehensive reviews to introduce the overall situation of the nanozyme field, the research on SOD-like nanozymes still lacks a systematic review. From the structure and mechanism of natural SOD enzymes to the structure and regulation of SOD-like nanozymes, and then to the measurement and application of nanozymes, this review systematically summarizes the recent progress in SOD-like nanozymes. The existing shortcomings and possible future research hotspots in the development of SOD-like nanozymes are summarized and prospected. We hope that this review would provide ideas and inspirations for further research on the catalytic mechanism and rational design of SOD-like nanozymes.

Insights into Manganese Superoxide Dismutase and Human Diseases

A Review of the Catalytic Mechanism of Human Manganese Superoxide Dismutase

Manganese Superoxide Dismutase Dysfunction and the Pathogenesis of Kidney Disease

Manganese Superoxide Dismutase: Guardian of the Powerhouse

Managing odds in stem cells: insights into the role of mitochondrial antioxidant enzyme MnSOD

Superoxide dismutase and neurological disorders

The Applications and Mechanisms of Superoxide Dismutase in Medicine, Food, and Cosmetics

Tumour Suppressor SIRT3 Deacetylates and Activates Manganese Superoxide Dismutase to Scavenge ROS.

Superoxide Dismutase Administration: A Review of Proposed Human Uses

Redox Signaling at the Crossroads of Human Health and Disease

Antioxidants Improve the Phenotypes of Dilated Cardiomyopathy and Muscle Fatigue in Mitochondrial Superoxide Dismutase-Deficient Mice

Superoxide dismutase: an updated review on its health benefits and industrial applications

SIRT1 Downregulation Mediated Manganese-induced Neuronal Apoptosis Through Activation of FOXO3a-Bim/PUMA Axis.

Superoxide dismutase nanozymes: an emerging star for anti-oxidation.

Revealing the atomic and electronic mechanism of human manganese superoxide dismutase product inhibition

Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma

Exploration of SOD3 from gene to therapeutic prospects: a brief review

Manganese‐Based Redox Homeostasis Disruptor for Inducing Intense Ferroptosis/Apoptosis through xCT Inhibition and Oxidative Stress Injury

Superoxide dismutase ameliorates oxidative stress and regulates liver transcriptomics to provide therapeutic benefits in hepatic inflammation

Mn-SOD Mimics and Their Potential Application in the Protection of Neurodegenerative Diseases

Imperative connotation of SODs in cancer: Emerging targets and multifactorial role of action